Anti-Neurodegenerative Agents from Natural Resources

A special issue of Medicines (ISSN 2305-6320).

Deadline for manuscript submissions: closed (31 December 2018) | Viewed by 6577

Special Issue Editor


E-Mail
Guest Editor
Department of Pharmacy, College of Pharmacy and Research Center for Bioresource and Health, Chungbuk National University, Cheongju 28160, Korea
Interests: application on dopamine biosynthesis and catabolism; signaling pathway of L-DOPA-induced oxidative neurotoxicity; ameliorative agents for neurodegenerative diseases, including Parkinson’s disease

Special Issue Information

Dear Colleagues,

Neurodegenerative diseases, including Alzheimer’s disease and memory deficits, Parkinson’s disease, affective disorders (anxiety and depression), chronic pain, and sleeping disorders, have been gradually increased by aging, and their symptoms should be relieved for quality of life of the patients. Various pharmacological agents have been developed to manage these diseases, but some of the long-term therapy carry significant adverse effects. Due to the limitations of medication, patients resort to complementary and alternative medicines and one of the medicines used is natural herbal resources/medicines.   

Recently, many bioactive components from natural resources have been reported that relive the symptoms of neurodegenerative diseases. However, the clinical applications of these components as mono- and combination-therapies and adjuvant agents still remain undeveloped. These reasons might be raised as the bioactive components are not able to show the desirable efficacy and may also induce the neurotoxicity by their long-term administrations in the animal models and clinical trials. The natural resources for neurodegenerative diseases can be proved the functional efficacy in order to develop as the candidates for herbal medicines, adjuvant agents and adjunctive phytonutrient agents.

The purpose of this Special Issue is to publish original research work related to the “Anti-Neurodegenerative Agents from Natural Resources”, mainly on protective activities of oxidative stress and mitochondrial dysfunction, neuroinflammation, excitoxicity, apoptosis and cell death, and protein aggregation and misfolding. Papers should contribute significantly to furthering scientific knowledge in the above-mentioned scientific fields.

Prof. Dr. Myung Koo Lee
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neurodegenerative diseases
  • evidence-based and adjuvant medicines
  • adjunctive phytonutrient agents
  • oxidative stress and mitochondrial dysfunction
  • neuroinflammation and excitoxicity
  • apoptosis and cell death
  • clinical application

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

17 pages, 1839 KiB  
Article
In Vitro Anti-Cholinesterase and Antioxidant Activity of Extracts of Moringa oleifera Plants from Rivers State, Niger Delta, Nigeria
by Lucky Legbosi Nwidu, Ekramy Elmorsy, Jonah Sydney Aprioku, Iyeopu Siminialayi and Wayne Grant Carter
Medicines 2018, 5(3), 71; https://doi.org/10.3390/medicines5030071 - 5 Jul 2018
Cited by 25 | Viewed by 5780
Abstract
This study evaluated Moringa oleifera extracts from two locations in Niger Delta for in vitro anti-cholinesterase and antioxidant activities. Methanolic, aqueous and ethanolic extracts of Moringa oleifera were evaluated for inhibition of acetylcholinesterase (AChE) activity, antioxidant properties, and total phenolic and flavonoid contents [...] Read more.
This study evaluated Moringa oleifera extracts from two locations in Niger Delta for in vitro anti-cholinesterase and antioxidant activities. Methanolic, aqueous and ethanolic extracts of Moringa oleifera were evaluated for inhibition of acetylcholinesterase (AChE) activity, antioxidant properties, and total phenolic and flavonoid contents using standard procedures. M. oleifera extracts possessed significant and concentration dependent AChE inhibitory activity for methanolic, aqueous, and ethanolic extracts. For the most potent extracts, the percentage AChE inhibition/IC50 (µg/mL) values were Moringa oleifera root methanolic extracts (MORME): ~80%/0.00845; Moringa oleifera root ethanolic extract 1 (MOREE1): ~90%/0.0563; Moringa oleifera root ethanolic extract 2 (MOREE2): ~70%/0.00175; and Moringa oleifera bark ethanolic extract (MOBEE): ~70%/0.0173. The descending order of AChE inhibitory potency of plant parts were: root > bark > leaf > flowers > seed. All M. oleifera methanolic extracts at a concentration of 1000 µg/mL displayed significant (p < 0.05–0.001) DPPH radical scavenging activity, with values of ~20–50% of that of ascorbic acid. The total phenolic content and total flavonoid content (TPC/TFC) of MORME, Moringa Oju bark methanolic extract (MOBME), MOREE1, MOREE2 and Moringa leaf ethanolic leaf extract (MLEE) were (287/254), (212/113), (223/185), (203/343) and (201/102) mg gallic acid equivalents/g and quercetin equivalents/g, respectively. There was an inverse correlation between plant extract AChE inhibition and total phenolic (p < 0.0001) and total flavonoid contents (p < 0.0012). In summary, this study revealed 5 of 19 extracts of M. oleifera that have potent in vitro anti-cholinesterase and antioxidant activities. Full article
(This article belongs to the Special Issue Anti-Neurodegenerative Agents from Natural Resources)
Show Figures

Graphical abstract

Back to TopTop